19.31
-0.25 (-1.28%)
| Previous Close | 19.56 |
| Volume | 66,377,525 |
| Price / Earnings (Forward) | 16.09 |
| Price / Sales | 2.39 |
| Price / Book | 3.65 |
| 52 Weeks Range | |
| TTM Dividend Yield | 4.34% |
| Profit Margin | 6.90% |
| Operating Margin (TTM) | 16.71% |
| Diluted EPS (TTM) | 0.560 |
| Quarterly Revenue Growth (YOY) | -3.90% |
| Quarterly Earnings Growth (YOY) | 8.80% |
| Total Debt/Equity (MRQ) | 88.04% |
| Current Ratio (MRQ) | 0.860 |
| Operating Cash Flow (TTM) | 1.91 B |
| Levered Free Cash Flow (TTM) | 1.79 B |
| Return on Assets (TTM) | 6.77% |
| Return on Equity (TTM) | 10.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Household & Personal Products (US) | Mixed | Bearish |
| Household & Personal Products (Global) | Mixed | Bearish | |
| Stock | Kenvue Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | NA |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Relative Valuation | NA |
| Financial Health | 0.0 |
| Macro Environment | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.62 |
Select this tab to load the latest available analysis.
|
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026. |
|
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Investment Style | Mid Value |
| % Held by Insiders | 0.04% |
| % Held by Institutions | 101.55% |
No data within this time range.
No data within this time range.
| TTM Dividend Yield | 4.34% |
| 3Y Average Dividend Yield | 2.28% |
| Payout Ratio | 145.54% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 12 Feb 2025 | 16 Jan 2025 | 26 Feb 2025 | 0.205 Cash |
| 13 Nov 2024 | 17 Oct 2024 | 27 Nov 2024 | 0.205 Cash |
| 14 Aug 2024 | 25 Jul 2024 | 28 Aug 2024 | 0.205 Cash |
| 07 May 2024 | 25 Apr 2024 | 22 May 2024 | 0.2 Cash |
| 13 Feb 2024 | 25 Jan 2024 | 28 Feb 2024 | 0.2 Cash |
| 07 Nov 2023 | 26 Oct 2023 | 22 Nov 2023 | 0.2 Cash |
| 25 Aug 2023 | 20 Jul 2023 | 07 Sep 2023 | 0.2 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2025 | 0.205 | 1 | 1.19 |
| 2024 | 0.810 | 4 | 3.79 |
| 2023 | 0.400 | 2 | 1.86 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |